Leicester Precision Medicine Institute

Improving Healthcare in an Ethnically Diverse Population

The Leicester Precision Medicine Institute (LPMI) unites the research expertise and facilities of the University of Leicester and University Hospitals Leicester NHS Trust with industry to provide new discoveries and medical innovations that impact on the healthcare of our ethnically diverse population.


Our mission is to discover, develop and advance early, accurate diagnosis that provides the best treatment and disease management options for individual patients.

New technologies measure more aspects of our personal health than ever before:

  • GenomicsLPMI logo
  • Proteomics
  • Metabolomics
  • Digital monitoring
  • Imaging
  • Clinical measures on electronic healthcare records

Integration of one or more of these approaches will provide a previously unavailable scale of information to better predict, diagnose and treat disease. Through the partners of the LPMI we will ensure the early delivery of this evolution in healthcare to our patients in the UHL NHS trust and the wider UK and world population.

For Industrial Partners Therapeutics front page Technologies and Expertise

Share this page:


BBC News - Public at risk from 'daily cocktail of pollution'


BBC News - Diabetes is actually five separate diseases, research suggests


East Midlands life sciences researchers and GSK launch medicines discovery collaboration for lung disease

The Universities of Leicester and Nottingham have announced a new strategic research collaboration with GSK, using genetics to aid the development of new medicines for Chronic Obstructive Pulmonary Disease (COPD) and related airway disorders. The £1.24m investment over three years provides an East Midlands-focused boost to the Life Sciences Sector Deal of the UK Government’s Industrial Strategy.

Capacity-building call for Precision Medicine Projects 2017/2018. Call launch event on Wed 29 Nov 2017 at 13.15-14.00 in the George Davies Centre - Lecture Theatre 2

Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment

Life sciences: industrial strategy published 30 August 2017.

Chief Medical Officer annual report 2016: Generation Genome published 4 July 2017.

Professor Louise Wain has been awarded a personal Chair (Professorship) and a £400,000 grant to conduct ground-breaking research into two incurable lung conditions - chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). The prestigious award was jointly funded by the university, the British Lung Foundation, and GSK.

International league table ranks Leicester among top 50 universities in the world for clinical medicine

The emerging blood test helping to spot cancer earlier

University Involved in a New Trial to Fight Cancer Caused by Asbestos

University of Leicester receives biggest ever gift from an individual - £2.7 million - for transformative kidney research

NIHR Biomedical Research Centre opens in Leicester

Simple urine test could stop ‘lung attacks’ and transform the lives of people with COPD

Asthma pill could reduce symptoms in severe sufferers

For General Enquiries:

Rebecca Ritchie

e: LPMI@le.ac.uk

t: +44 (0)116 373 6498

For Academic Enquiries:

Professor Martin Tobin

e: mt47@le.ac.uk

For Commercial Enquiries: